[Genetic mutations and molecularly-targeted drugs in hypereosinophilic syndromes]

Arerugi. 2011 Feb;60(2):167-77.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Gene Fusion
  • Humans
  • Hypereosinophilic Syndrome / drug therapy*
  • Hypereosinophilic Syndrome / genetics*
  • Male
  • Molecular Targeted Therapy*
  • Mutation
  • Receptors, Platelet-Derived Growth Factor / genetics*
  • mRNA Cleavage and Polyadenylation Factors / genetics*

Substances

  • FIP1L1 protein, human
  • mRNA Cleavage and Polyadenylation Factors
  • Receptors, Platelet-Derived Growth Factor